The FDA has granted priority review status for two new indications of dasatinib (Sprycel), according to the drug 's developer. (Source: CancerNetwork)
from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uOgWS5
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,